These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 8772663)

  • 1. Unexpected keys in cell biochemistry imaging: some lessons from technetium-99m-sestamibi.
    Mariani G
    J Nucl Med; 1996 Mar; 37(3):536-8. PubMed ID: 8772663
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro uptake of technetium-99m-teboroxime in carcinoma cell lines and normal cells: comparison with technetium-99m-sestamibi and thallium-201.
    Maublant JC; Zhang Z; Rapp M; Ollier M; Michelot J; Veyre A
    J Nucl Med; 1993 Nov; 34(11):1949-52. PubMed ID: 8229240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ECG-gated and static technetium-99m-SESTAMIBI planar myocardial perfusion imaging: a comparison with thallium-201 and study of observer variabilities.
    Verzijlbergen JF; Cramer MJ; Niemeyer MG; Ascoop CA; Van der Wall EE; Pauwels EK
    Am J Physiol Imaging; 1990; 5(2):60-7. PubMed ID: 2147553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Same-day acquisition protocol for imaging with technetium-99m-sestamibi.
    Garcia EV
    J Nucl Med; 1992 Mar; 33(3):468. PubMed ID: 1531503
    [No Abstract]   [Full Text] [Related]  

  • 5. Technetium-99m-sestamibi uptake by human benign and malignant breast tumor cells: correlation with mdr gene expression.
    Cordobes MD; Starzec A; Delmon-Moingeon L; Blanchot C; Kouyoumdjian JC; Prévost G; Caglar M; Moretti JL
    J Nucl Med; 1996 Feb; 37(2):286-9. PubMed ID: 8667063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of technetium-99m sestamibi myocardial imaging in the emergency department evaluation of chest pain.
    Summers RL; Tisdale B; Kolb JC; Woodward LA
    J Miss State Med Assoc; 1998 May; 39(5):176-9. PubMed ID: 9610074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thallium-201 and technetium-99m-sestamibi for assessing viable myocardium.
    Bonow RO; Dilsizian V
    J Nucl Med; 1992 May; 33(5):815-8. PubMed ID: 1533248
    [No Abstract]   [Full Text] [Related]  

  • 8. Assessment of myocardial viability by sestamibi scintigraphy.
    De Geeter F
    J Nucl Med; 1994 May; 35(5):921-2. PubMed ID: 8176483
    [No Abstract]   [Full Text] [Related]  

  • 9. Animal models in radiotracer design of a Tc-labelled myocardial perfusion imaging agent.
    Mousa SA
    Am J Physiol Imaging; 1991; 6(1):16-25. PubMed ID: 1828162
    [No Abstract]   [Full Text] [Related]  

  • 10. Localization of technetium-99m-sestamibi in diffuse myelodysplastic processes.
    Reiman RE; Fetters JK
    J Nucl Med; 1996 Mar; 37(3):471-3. PubMed ID: 8772649
    [No Abstract]   [Full Text] [Related]  

  • 11. Uptake of technetium-99m-teboroxime in cultured myocardial cells: comparison with thallium-201 and technetium-99m-sestamibi.
    Maublant JC; Moins N; Gachon P; Renoux M; Zhang Z; Veyre A
    J Nucl Med; 1993 Feb; 34(2):255-9. PubMed ID: 8429344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Myocardial perfusion imaging with Tc-99m isonitriles].
    Tamaki N
    Rinsho Hoshasen; 1987 Apr; 32(4):471-7. PubMed ID: 3613181
    [No Abstract]   [Full Text] [Related]  

  • 13. Myocardial technetium-99m-tetrofosmin and technetium-99m-sestamibi kinetics in normal subjects and patients with coronary artery disease.
    Münch G; Neverve J; Matsunari I; Schröter G; Schwaiger M
    J Nucl Med; 1997 Mar; 38(3):428-32. PubMed ID: 9074532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous silent myocardial ischemia assessed by technetium-99m-sestamibi imaging.
    Samman B; Hahn SD; Messinger DE; Heller GV
    J Nucl Med; 1993 Jan; 34(1):134-6. PubMed ID: 8418256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Newer technetium-99m--labeled myocardial perfusion imaging agents: clinical indications.
    Bisson G; Hendel RC; Taillefer R
    Am J Card Imaging; 1994 Jul; 8(3):213-22. PubMed ID: 7950172
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison between technetium-99m-sestamibi and hydrogen-3-daunomycin myocardial cellular retention in vitro.
    Cayre A; Moins N; Finat-Duclos F; Verrelle P; Maublant J
    J Nucl Med; 1997 Nov; 38(11):1674-7. PubMed ID: 9374331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is redistribution important in sestamibi myocardial imaging?
    Iskandrian AS
    J Nucl Med; 1991 Oct; 32(10):1966-7. PubMed ID: 1833518
    [No Abstract]   [Full Text] [Related]  

  • 18. Sestamibi and the issue of tissue crosstalk.
    Watson DD; Smith WH
    J Nucl Med; 1990 Aug; 31(8):1409-11. PubMed ID: 2143530
    [No Abstract]   [Full Text] [Related]  

  • 19. [Scintigraphy of the heart--a new generation of radiopharmaceutical agents, Technetium 99m-labeled isonitrile compounds].
    Wasilewski J; Pasyk S
    Kardiol Pol; 1991; 34(1):33-8. PubMed ID: 2051711
    [No Abstract]   [Full Text] [Related]  

  • 20. [Technetium-99m isonitrile versus thallium 201 in coronary disease].
    Candell Riera J; Aguadé Bruix S; Castell Conesa J; Cortadellas Angel J
    Rev Esp Cardiol; 1994; 47 Suppl 4():101-15. PubMed ID: 7863075
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.